| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
173,970,000 |
| Market
Cap: |
4.71(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$15.01 - $43.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,500 |
115,745 |
1,772,132 |
2,889,102 |
| Total Sell Value |
$75,793 |
$4,772,807 |
$61,791,093 |
$73,490,989 |
| Total People Sold |
1 |
3 |
6 |
6 |
| Total Sell Transactions |
2 |
8 |
16 |
31 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Homcy Charles J |
Chairman of Pharmaceuticals |
• • – |
2020-09-29 |
4 |
AS |
$37.50 |
$682,500 |
D/D |
(18,200) |
1,203,767 |
|
84% |
|
| Homcy Charles J |
Chairman of Pharmaceuticals |
• • – |
2020-09-25 |
4 |
AS |
$36.68 |
$2,985,455 |
D/D |
(81,057) |
1,221,967 |
|
97% |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-18 |
4 |
AS |
$42.01 |
$105,024 |
D/D |
(2,500) |
12,568 |
|
36% |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-18 |
4 |
OE |
$17.00 |
$42,500 |
D/D |
2,500 |
15,068 |
|
- |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-09-18 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
267,751 |
|
36% |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-09-18 |
4 |
OE |
$0.16 |
$2,212 |
D/D |
10,000 |
277,751 |
|
- |
|
| Scheller Richard H |
See Remarks |
• • – |
2020-09-16 |
4 |
AS |
$37.50 |
$937,500 |
D/D |
(25,000) |
138,427 |
|
51% |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-15 |
4 |
AS |
$37.06 |
$92,652 |
D/D |
(2,500) |
12,568 |
|
50% |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-15 |
4 |
OE |
$17.00 |
$42,500 |
D/D |
2,500 |
15,068 |
|
- |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-11 |
4 |
AS |
$35.02 |
$70,047 |
D/D |
(2,000) |
12,568 |
|
96% |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-11 |
4 |
OE |
$0.34 |
$680 |
D/D |
2,000 |
14,568 |
|
- |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-09-01 |
4 |
AS |
$27.89 |
$287,334 |
D/D |
(10,000) |
267,751 |
|
138% |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-09-01 |
4 |
OE |
$0.16 |
$1,600 |
D/D |
10,000 |
277,751 |
|
- |
|
| Turtle Cameron |
See Remarks |
• – – |
2020-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,745 |
12,568 |
|
- |
|
| Sinha Uma |
Chief Scientific Officer |
• – – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
468 |
15,991 |
|
- |
|
| Stolz Brian M. |
Chief Operating Officer |
• – – |
2020-08-16 |
4 |
D |
$28.53 |
$15,749 |
D/D |
(552) |
24,615 |
|
- |
|
| Stolz Brian M. |
Chief Operating Officer |
• – – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,595 |
25,167 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2020-08-16 |
4 |
D |
$28.53 |
$50,612 |
D/D |
(1,774) |
4,689,080 |
|
- |
|
| Kumar Neil |
CEO and President |
• • – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,690,854 |
|
- |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-08-16 |
4 |
D |
$28.53 |
$155,774 |
D/D |
(5,460) |
267,751 |
|
- |
|
| Henderson Michael Thomas |
Chief Business Officer |
• – – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,812 |
273,211 |
|
- |
|
| Stephenson Brian C |
See Remarks |
• – – |
2020-08-16 |
4 |
D |
$28.53 |
$16,861 |
D/D |
(591) |
288,967 |
|
- |
|
| Stephenson Brian C |
See Remarks |
• – – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,709 |
289,558 |
|
- |
|
| Yau Yi Ching |
Chief Accounting Officer |
• – – |
2020-08-16 |
4 |
D |
$28.53 |
$3,937 |
D/D |
(138) |
993 |
|
- |
|
| Yau Yi Ching |
Chief Accounting Officer |
• – – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
398 |
1,131 |
|
- |
|
294 Records found
|
|
Page 8 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (0.26%) 
